17,18 In a post-hoc analysis of the SUSTAIN-6 study, the additional risk factors of speed of hemoglobin A1c reduction with treatment, poor baseline glycemic control and insulin use at the initiation of GLP-1/GIP agonist treatment were reported ( Table 2 )
When reviewing the database with NAD + precursors as interventions yet with the other term input using aging , it indicates that there are currently no ongoing or published clinical trials for NA, 2 trials exploring NAM, 4 trials examining NAD + , 5 trials investigating NMN, and 18 trials focused on NR in elderly cohorts
PMID: 30356415
One small study found that ashwagandha helped people lose 3% of their body weight in 8 weeksbut only 14 of the 50 people studied were women, and half of them got a placebo, so thats much, much too limited a finding to cheer about
Looking to save money on your healthcare expenses next year
Risperdone (RisperdalTM) which was approved by the FDA in 2006 for irritability (aggression, self-injury, temper tantrums, and rapid mood changes) in individuals with ASD, is the best studied
